Long-term results of combined treatment of colorectal cancer patients with liver metastases


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The results of univariate and multivariate analyzes for the detection of significant factors predicting the survival of colorectal cancer patients with liver metastases are presented. The following significantly significant factors of favorable prognosis were established: achievement of III-IV degrees therapeutic pathomorphosis; normalization of the cancer-embryonic antigen levels of after preoperative chemotherapy; the prevalence of metastatic liver damage within one lobe. A treatment algorithm that has made it possible to achieve high survival rates has been proposed.

全文:

受限制的访问

作者简介

E. Chernoglazova

FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH

Email: ev-onco@mail.ru
PhD, Senior Researcher at Department of Chemotherapy and Combined Treatment of Malignant Tumors

G. Vyshinskaya

FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH

I. Sagaidak

FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH

L. Rotobelskaya

FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH

M. Abramov

FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH

D. Filonenko

FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH

参考

  1. Каприн А.Д., Старинский В.В., Петрова Г.В. (ред.). Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). М., 2016. 250 с.
  2. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136(5):E359-86.
  3. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: colon cancer. Available at: http://www.nccn.org. Accessed November 8, 2016.
  4. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: rectal cancer. Available at: http://www.nccn.org. Accessed November 8, 2016.
  5. Ciliberto D., Prati U., Roveda L., Barbieri V., Staropoli N., Abbruzzese A., Caraglia M., Di Maio M., Flotta D., Tassone P., Tagliaferri P. Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and metaanalysis of randomized controlled trials. Oncol. Rep. 2012;27(6):1849-56.
  6. Adam R., Delvart V., Pascal G., Valeanu A., Castaing D., Azoulay D., Giacchetti S., Paule B., Kunstlinger F., Ghémard O., Levi F., Bismuth H. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg. 2004;240:644-57.
  7. Delaunoit T., Alberts S.R., Sargent D.J., Green E., Goldberg R.M., Krook J., Fuchs C., Ramanathan R.K., Williamson S.K., Morton R.F., Findlay B.P Chemotherapy permits resection of metastatic colorectal cancer: Experience from intergroup N9741. Ann. Oncol. 2005;16(3):425-29.
  8. Pawlik T.M., Schulick R.D., Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13(1):51-64.
  9. Schmoll H.J., Van Cutsem E., Stein A., Valentini V., Glimelius. B., Haustermans K., Nordlinger B., van de Velde C.J., Balmana J., Regula J., Nagtegaal I.D., Beets-Tan R.G., Arnold D., Ciardiello F., Hoff P., Kerr D., Köhne C.H., Labianca R., Price T., Scheithauer W., Sobrero A., Tabernero J., Aderka D., Barroso S., Bodoky G., Douillard J.Y., Ghazaly H.E., Gallardo J., Garin A., Glynne-Jones R., Jordan K., Meshcheryakov A., Papamichail D., Pfeiffer P., Souglakos I., Turhal S., Cervantes A. ESMO consensus guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision making. Ann. Oncol. 2012;23(10):2479-516.
  10. Патютко Ю.И., Сагайдак И.В., Поляков А.Н., Подлужный Д.В., Черноглазова Е.В., Чистякова О.В., Чучуев Е.С., Гахраманов А.Д., Косырев В.Ю. Хирургическое и комбинированное лечение больных колоректальным раком с метастатическим поражением печени. Онкол. колопроктол. 2011;1:32-9.
  11. Tomlinson J.S., Jarnagin W.R., De Matteo R.P., Fong Y., Kornprat P., Gonen M., Kemeny N., Brennan M.F., Blumgart L.H., D'Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. J. Clin. Oncol. 2007;25(29):4575-80.
  12. Tsai M.S., Su Y.H., Ho M.C. Clinico-pathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann. Surg. Oncol. 2007;14(2):786-94.
  13. Kanas G.P., Taylor A., Primrose J.N., Langeberg W.J., Kelsh M.A., Mowat F.S., Alexander D.D., Choti M.A., Poston G. Survival after liver resection in metastatic colorectal cancer: review and metaanalysis of prognostic factors. Clin. Epidemiol. 2012;4:283-301.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2017
##common.cookie##